Anti-CO6A2/ COL6A2/ BTHLM1 functional antibody

Anti-CO6A2/ COL6A2/ BTHLM1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to COL6A2/COL6A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0112-Ab-1/ GM-Tg-hg-SE0112-Ab-2Anti-Human COL6A2 monoclonal antibodyHuman
GM-Tg-rg-SE0112-Ab-1/ GM-Tg-rg-SE0112-Ab-2Anti-Rat COL6A2 monoclonal antibodyRat
GM-Tg-mg-SE0112-Ab-1/ GM-Tg-mg-SE0112-Ab-2Anti-Mouse COL6A2 monoclonal antibodyMouse
GM-Tg-cynog-SE0112-Ab-1/ GM-Tg-cynog-SE0112-Ab-2Anti-Cynomolgus/ Rhesus macaque COL6A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0112-Ab-1/ GM-Tg-felg-SE0112-Ab-2Anti-Feline COL6A2 monoclonal antibodyFeline
GM-Tg-cang-SE0112-Ab-1/ GM-Tg-cang-SE0112-Ab-2Anti-Canine COL6A2 monoclonal antibodyCanine
GM-Tg-bovg-SE0112-Ab-1/ GM-Tg-bovg-SE0112-Ab-2Anti-Bovine COL6A2 monoclonal antibodyBovine
GM-Tg-equg-SE0112-Ab-1/ GM-Tg-equg-SE0112-Ab-2Anti-Equine COL6A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0112-Ab-1/ GM-Tg-hg-SE0112-Ab-2; GM-Tg-rg-SE0112-Ab-1/ GM-Tg-rg-SE0112-Ab-2;
GM-Tg-mg-SE0112-Ab-1/ GM-Tg-mg-SE0112-Ab-2; GM-Tg-cynog-SE0112-Ab-1/ GM-Tg-cynog-SE0112-Ab-2;
GM-Tg-felg-SE0112-Ab-1/ GM-Tg-felg-SE0112-Ab-2; GM-Tg-cang-SE0112-Ab-1/ GM-Tg-cang-SE0112-Ab-2;
GM-Tg-bovg-SE0112-Ab-1/ GM-Tg-bovg-SE0112-Ab-2; GM-Tg-equg-SE0112-Ab-1/ GM-Tg-equg-SE0112-Ab-2
Products NameAnti-COL6A2 monoclonal antibody
Formatmab
Target NameCOL6A2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-COL6A2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0112-Ag-1Recombinant multi-species CO6A2/ COL6A2/ BTHLM1 protein
    ORF Viral VectorpGMLP001476human COL6A2 Lentivirus plasmid
    ORF Viral VectorvGMLP001476human COL6A2 Lentivirus particle


    Target information

    Target IDGM-SE0112
    Target NameCOL6A2
    Gene ID1292,12834,361821,709493,100856491,101100658,282194,100055332
    Gene Symbol and SynonymsBTHLM1,Col6a-2,COL6A2,PP3610,UCMD1
    Uniprot AccessionP12110
    Uniprot Entry NameCO6A2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000142173
    Target ClassificationN/A

    The target: COL6A2, gene name: COL6A2, also named as BTHLM1, PP3610, UCMD1. This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.